Rifaximin for IBS without constipation

February 2011
Internal Medicine Alert;Mar2011 Pharmacology Watch, p1
The article reports on a study which examines the effectiveness of Rifaximin to treat patients suffered from irritable bowel syndrome.


Related Articles

  • Rifaximin for IBS without constipation.  // Internal Medicine Alert;2/15/2011 Supplement 2, p23 

    The article reports that the use of rifaximin for patients with irritable bowel syndrome (IBS) without constipation has provided a statistically significant improvement in global symptoms, bloating, abdominal pain and stool consistency.

  • Rifaximin for IBS without constipation. Elliott, William T. // Infectious Disease Alert;Mar2011 Clinical Bri, p1 

    The article reports on a study published in the "New England Journal of Medicine," which found that rifaximin, an oral antibiotic, can treat symptoms of irritable bowel syndrome (IBS).

  • Link found between IBD and child antibiotic use.  // Pulse;11/3/2010, Vol. 70 Issue 33, p12 

    The article reports on the observational study by Dr. Anders Hviid and his group which found a link between prescribing antibiotics in children and the subsequent development of irritable bowel disease (IBD).

  • Antibiotic provides lasting relief for IBS.  // Clinical Advisor;Mar2011, Vol. 14 Issue 3, p30 

    The article reports on the use of antibiotic therapy for the treatment of irritable bowel syndrome (IBS).

  • Reducing childhood antibiotic use may help curb rising IBD incidence.  // Reactions Weekly;10/20/2012, Issue 1424, p1 

    The article focuses on a study which examined the link between childhood antibiotic use and the risk of developing irritable bowel disease.

  • Broad-Spectrum Antibiotic Offers Hope For IBS.  // RN;Jan2007, Vol. 70 Issue 1, p62 

    This article discusses research done on the effect of a non-absorbed oral antibiotic on the symptoms of the irritable bowel syndrome. It refers to a study by M. Pimentel and colleagues in a 2006 issue of the "Annals of Internal Medicine." Symptoms of this syndrome include bloating, cramps,...

  • Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin. Peralta, Sergio; Cottone, Claudia; Doveri, Tiziana; Almasio, Piero Luigi; Craxi, Antonio; Amarapurkar, Deepak Narayan // World Journal of Gastroenterology;6/7/2009, Vol. 15 Issue 21, p2628 

    AIM: To estimate the prevalence of small intestinal bacterial overgrowth (SIBO) in our geographical area (Western Sicily, Italy) by means of an observational study, and to gather information on the use of locally active, non-absorbable antibiotics for treatment of SIBO. METHODS: Our survey...

  • CONCERNS ABOUT ANTIBIOTICS FOR ACNE AND IBS.  // Contemporary Pediatrics;Sep2010, Vol. 27 Issue 9, p14 

    No abstract available.

  • Antibacterial Chemoprophylaxis in the Prevention of Traveler's Diarrhea: Evaluation of Poorly Absorbed Oral Rifaximin. DuPont, Herbert L.; Zhi-Dong Jiang; Okhuysen, Pablo C.; Ericsson, Charles D.; de la Cabada, F. Javier; Ke, Shi; DuPont, Margaret W.; Martinez-Sandoval, Francisco // Clinical Infectious Diseases;12/2/2005, Vol. 41, pS571 

    The use of antibacterial drugs was first shown to effectively reduce the occurrence of traveler's diarrhea nearly 50 years ago. The approach was not encouraged for general use by a Consensus Development Conference in 1985 because of concerns about adverse effects of the drugs and the possible...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics